Celldex (CLDX) Tops Q3 EPS by 4c

Celldex (NASDAQ: CLDX) reported Q3 EPS of ($0.29), $0.04 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $850 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'
• BofA lists top 5 themes driving next $1tn in incremental semi sales